Correlation Between Tarsus Pharmaceuticals and Fresh2

Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Fresh2 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Fresh2 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tarsus Pharmaceuticals and Fresh2 Group, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Fresh2 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Fresh2. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Fresh2.

Diversification Opportunities for Tarsus Pharmaceuticals and Fresh2

-0.46

Correlation Coefficient

Tarsus Pharmaceuticals  Fresh2

Very good diversification

The 3 months correlation between Tarsus and Fresh2 is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Fresh2 Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fresh2 Group and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Fresh2. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fresh2 Group has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Fresh2 go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and Fresh2

Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 0.22 times more return on investment than Fresh2. However, Tarsus Pharmaceuticals is 4.51 times less risky than Fresh2. It trades about 0.26 of its potential returns per unit of risk. Fresh2 Group is currently generating about -0.38 per unit of risk. If you would invest  5,066  in Tarsus Pharmaceuticals on October 9, 2024 and sell it today you would earn a total of  442.00  from holding Tarsus Pharmaceuticals or generate 8.72% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	75.0%
Values	Daily Returns

Tarsus Pharmaceuticals  vs.  Fresh2 Group

Tarsus Pharmaceuticals

Risk-Adjusted Performance

25 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 25 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Fresh2 Group

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Fresh2 Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Tarsus Pharmaceuticals and Fresh2

The main advantage of trading using opposite Tarsus Pharmaceuticals and Fresh2 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Fresh2 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fresh2 will offset losses from the drop in Fresh2's long position.

The idea behind Tarsus Pharmaceuticals and Fresh2 Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.